Selected monoclonal antibodies in ALL and AML
| Selected monoclonal antibodies in ALL | Selected monoclonal antibodies in AML | ||
|---|---|---|---|
| Rituximab | anti-CD20 antibody | SGN-CD33A | anti-CD33 pyrrolobenzodiazepine dimer |
| Ofatumumab | anti-CD20 antibody | AMG 330 | anti-CD33 and CD3, bi-specific T cell engager antibody |
| Epratuzumab | anti-CD22 antibody | MGD006 | anti-CD123 and CD3, dual affinity retargeting molecule |
| Alemtuzumab | anti-CD52 antibody | CSL362 | anti-CD123 antibody |
| Inotuzumab ozogamicin | Monoclonal anti-CD22 immunotoxin | SL-401 | diphtheria toxin interleukin-3 fusion protein against CD123 |
| Blinatumomab | bi-specific T cell engager antibody | ||
| Moxetunomab pasudotox | conjugated immunotoxin targeting CD22 | ||